LOFFREDO, Francesco
 Distribuzione geografica
Continente #
EU - Europa 3.142
NA - Nord America 1.385
AS - Asia 1.332
SA - Sud America 187
Continente sconosciuto - Info sul continente non disponibili 92
AF - Africa 21
OC - Oceania 4
Totale 6.163
Nazione #
RU - Federazione Russa 2.256
US - Stati Uniti d'America 1.346
SG - Singapore 514
CN - Cina 274
IE - Irlanda 251
IT - Italia 176
VN - Vietnam 174
BR - Brasile 160
HK - Hong Kong 142
FR - Francia 123
GB - Regno Unito 88
DE - Germania 82
KR - Corea 74
IN - India 50
UA - Ucraina 40
BD - Bangladesh 34
GR - Grecia 26
FI - Finlandia 25
SE - Svezia 21
AT - Austria 15
CA - Canada 14
AR - Argentina 11
BE - Belgio 11
NL - Olanda 11
JP - Giappone 9
TR - Turchia 9
ID - Indonesia 7
IQ - Iraq 7
PL - Polonia 7
SA - Arabia Saudita 7
EC - Ecuador 5
MA - Marocco 5
MX - Messico 5
PY - Paraguay 5
UZ - Uzbekistan 5
AU - Australia 4
ES - Italia 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
HN - Honduras 3
JO - Giordania 3
KZ - Kazakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
BB - Barbados 2
CL - Cile 2
DZ - Algeria 2
ET - Etiopia 2
JM - Giamaica 2
KE - Kenya 2
PA - Panama 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
EU - Europa 1
GA - Gabon 1
GP - Guadalupe 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MR - Mauritania 1
MY - Malesia 1
NP - Nepal 1
PK - Pakistan 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 6.072
Città #
Moscow 832
Singapore 262
Dublin 249
San Jose 196
Santa Clara 186
Hong Kong 138
Jacksonville 103
Ashburn 97
Chandler 82
Seoul 73
Ho Chi Minh City 54
Beijing 47
Ann Arbor 44
Hefei 44
Naples 42
Hanoi 38
Princeton 32
Roxbury 29
Dallas 23
Medford 21
Bremen 20
Los Angeles 19
Nuremberg 18
Chennai 17
Da Nang 17
Orem 17
Memphis 16
Bengaluru 15
New York 15
Seattle 15
São Paulo 15
Cambridge 14
The Dalles 13
Wilmington 12
Atlanta 11
Brussels 11
Council Bluffs 11
Turku 11
Des Moines 9
Vienna 9
Milan 8
Sennori 8
Amsterdam 7
Boardman 7
Mumbai 7
Chicago 6
Guangzhou 6
Haiphong 6
Mountain View 6
Munich 6
Rome 6
Warsaw 6
Frankfurt am Main 5
Helsinki 5
Miami 5
Montreal 5
Nha Trang 5
Rio de Janeiro 5
Tokyo 5
Torre Annunziata 5
Turin 5
Woodbridge 5
Bến Tre 4
Curitiba 4
Dhaka 4
Houston 4
Jinan 4
Nanjing 4
New Haven 4
Ninh Bình 4
North Kansas City 4
Ottawa 4
San Mateo 4
Tashkent 4
Trieste 4
Tây Ninh 4
Amman 3
Asunción 3
Aversa 3
Baku 3
Brooklyn 3
Buenos Aires 3
Columbus 3
Denver 3
Düsseldorf 3
Erbil 3
Ercolano 3
Falkenstein 3
Hải Dương 3
Indpls 3
Jeddah 3
Manaus 3
Manchester 3
Paris 3
Phú Nhuận 3
Poplar 3
Reston 3
San Francisco 3
San Prisco 3
Secaucus 3
Totale 3.134
Nome #
C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. 242
C-reactive protein induces expression of matrix metalloproteinase-9: A possible link between inflammation and plaque rupture. 168
Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1 162
An unusual case of retrobulbar haemorrhage following a transoesophageal echocardiogram: a rare but a potential severe complication 143
Oxidative stress within the coronary circulation is associated with reduction in endothelium-dependent coronary vasodilation in patients with acute coronary syndromes. 137
Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries 134
Arrhythmogenic Left Ventricular Cardiomyopathy: From Diagnosis to Risk Management 132
Evolving Concepts in LDL-Lowering Strategies: Are We There? 130
Novel antithrombotic strategies in cardiovascular diseases 130
Animal models of platelet-dependent thrombosis 129
Cardiovascular aging: the unveiled enigma from bench to bedside 126
Constrictive Pericarditis After a Stab Wound of the Chest 125
Hypercoagulability and atherothrombosis: Clinical suggestions and perspectives 125
Circulating Growth Differentiation Factor 11/8 Levels Decline with Age 125
Asymptomatic Stroke in the Setting of Percutaneous Non-Coronary Intervention Procedures 123
Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair 122
Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence 121
Immune-inflammatory activation in acute coronary syndromes: A look into the heart of unstable coronary plaque 120
Safety of transesophageal echocardiogram in anticoagulated patients 118
Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding 116
Echocardiographic evaluation of centenarians in Trieste 115
Evolving Concepts of the SCORE System: Subtracting Cholesterol from Risk Estimation: A Way for a Healthy Longevity? 112
Keep PNUTS in your heart 112
Apoptosis, a useful marker in the management of hot‐phase cardiomyopathy? 110
Engineered heart tissue maturation inhibits cardiomyocyte proliferative response to cryoinjury 109
Oxidized Low-Density Lipoproteins Induce Tissue Factor Expression in T-Lymphocytes via activation of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 109
Catch the Cath or Not? A Hamletic Dilemma after 10 Years 107
Fulminant Myocarditis Unmasking Adult-Onset Still's Disease and Desmoplakin Truncation 107
Artificial intelligence for left ventricular hypertrophy detection and differentiation on echocardiography, cardiac magnetic resonance and cardiac computed tomography: A systematic review 105
Secretory phospholipase A(2) type IIA levels are increased in the coronary circulation of patients with acute coronary syndromes 104
Non-Conventional Risk Factors: "Fact" or "Fake" in Cardiovascular Disease Prevention? 103
The Desmoplakin Phenotype Spectrum: Is the Inflammation the "Fil Rouge" Linking Myocarditis, Arrhythmogenic Cardiomyopathy, and Uncommon Autoinflammatory Systemic Disease? 102
Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. 101
Role of circulating factors in cardiac aging 98
Heart failure with preserved ejection fraction: Molecular pathways of the aging myocardium 98
Pathways for salvage and protection of the heart under stress: novel routes for cardiac rejuvenation 96
Exogenous GDF11, but not GDF8, reduces body weight and improves glucose homeostasis in mice 94
Therapeutic vasculogenesis: It takes two 92
The overall echogenicity (GSM) of carotid intima-media complex shows a positive correlation with arterial stiffness in hypertensive patients 89
Epigenetic mechanisms underlying the beneficial effects of cardiac rehabilitation. An overview from the working groups of “cellular and molecular biology of the heart” and “cardiac rehabilitation and cardiovascular prevention” of the Italian Society of Cardiology (SIC) 88
Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy 88
Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle 88
Targeted Approach to Distinguish and Determine Absolute Levels of GDF8 and GDF11 in Mouse Serum 88
Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors 87
Homocysteine in the Cardiovascular Setting: What to Know, What to Do, and What Not to Do 86
Cardio-Pulmonary Features of Long COVID: From Molecular and Histopathological Characteristics to Clinical Implications 85
Targeted delivery to cartilage is critical for in vivo efficacy of insulin-like growth factor 1 in a rat model of osteoarthritis 83
Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation 74
Peripheral artery disease and abdominal aortic aneurysm: The forgotten diseases in covid-19 pandemic. results from an observational study on real-world management 70
Sodium Nitroprusside: The Forgotten Vasodilator? A Brief Guide for Informed and Safe Use from Heart Failure to Hypertensive Crisis and Aortic Dissection 69
Targeting Obesity in Cardiovascular Disease Management: Cardiac Adipose Tissue Is a Real Biomarker! 65
Mitophagy modulation for the treatment of cardiovascular diseases 64
Acquired mild aortic regurgitation following left main stent implantation 62
The NO Pathway as a Target in Patients with Stable and Advanced Heart Failure: An Additional Arrow in Our Quiver! 60
Isolated Common Iliac Aneurysm and Dilated Left Ventricle: Kill Two Birds with One Stone? 57
The Conundrum of Biventricular Takotsubo Syndrome After Heart Transplantation: A Case Report 47
Radiology Quiz: The real Macaroni sign? 34
Clinical presentation and echocardiographic characteristics of women with peripartum cardiomyopathy: Insights from the Italian Multicentre Registry 27
Diffuse Cutaneous Systemic Sclerosis Complicated by Serum Amyloid A Protein Cardiac Amyloidosis and Cardiogenic Shock 23
Aims and Rationale of a National Registry Integrating Clinical, Echocardiographic, and Multi-Omics Profiling to Promote Precision Medicine in Peripartum Cardiomyopathy 22
APOE Genotype and Endothelial Biomarkers: Towards Personalized Cardiovascular Screening 22
A Particular Case of Myocardial Injury 17
Modulation of Cardiometabolic Risk by Vitamin D and K2: Simple Supplementation or Real Drug? Uncovering the Pharmacological Properties 17
Mechanical load inhibits cancer growth in mouse and human hearts 12
Integrating Genetic, Clinical, and Histopathological Data for Definitive Diagnosis of PRKAG2-Related Disease 9
Conventional and Non‑conventional Risk Factors: A Need for an Innovative Integration in Cardiovascular Disease 6
Assessment of Peripheral Arterial (Normal) Flows in Multiple Vascular Territories in Patients Receiving Mechanical Cardiac Support 6
Colchicine in patients with chronic inflammatory cardiomyopathy: rationale and design of the CMP-MYTHiC 5
The Genetic Stamp of Lipoprotein(a): Moving Beyond LDL for Cardiovascular Risk Estimation 4
Renal resistance index reveals ‘driving effect’ of vericiguat for heart failure therapy: the possible way for guideline-directed medical therapy implementation? 4
Lp(a) as Driver for Lipid Lowering Strategy Optimization in Patients at High and Very-High Risk: Beyond LDL-C 3
Totale 6.163
Categoria #
all - tutte 21.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.629


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022201 0 4 6 4 77 3 3 6 7 6 14 71
2022/2023438 59 5 6 12 48 33 0 23 232 5 10 5
2023/2024187 13 14 19 7 69 4 4 5 3 5 22 22
2024/2025672 8 5 3 4 114 93 76 115 84 55 62 53
2025/20264.048 179 158 163 144 296 2.185 234 208 144 115 146 76
2026/2027157 84 73 0 0 0 0 0 0 0 0 0 0
Totale 6.163